Accordingly, programs may also choose whether to refer only infants with two CFTR variants for diagnostic follow-up and sweat testing after screening for CF-causing variants in CFTR2 or refer infants with one or two variants for NBS follow-up (Figure 2; see also Considerations for Implementation). The gene discussed is CFTR; the disease is cystic fibrosis.